Pharma-Bio Serv (PBSV) FCF Margin (2016 - 2025)
Historic FCF Margin for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to 12.99%.
- Pharma-Bio Serv's FCF Margin rose 163600.0% to 12.99% in Q4 2025 from the same period last year, while for Oct 2025 it was 2.46%, marking a year-over-year increase of 51800.0%. This contributed to the annual value of 2.46% for FY2025, which is 51800.0% up from last year.
- Pharma-Bio Serv's FCF Margin amounted to 12.99% in Q4 2025, which was up 163600.0% from 11.94% recorded in Q3 2025.
- In the past 5 years, Pharma-Bio Serv's FCF Margin ranged from a high of 30.47% in Q1 2024 and a low of 29.47% during Q2 2024
- In the last 5 years, Pharma-Bio Serv's FCF Margin had a median value of 6.98% in 2022 and averaged 1.87%.
- Its FCF Margin has fluctuated over the past 5 years, first plummeted by -487000bps in 2024, then soared by 397400bps in 2025.
- Quarter analysis of 5 years shows Pharma-Bio Serv's FCF Margin stood at 17.17% in 2021, then plummeted by -69bps to 5.35% in 2022, then skyrocketed by 61bps to 8.62% in 2023, then crashed by -139bps to 3.37% in 2024, then soared by 486bps to 12.99% in 2025.
- Its last three reported values are 12.99% in Q4 2025, 11.94% for Q3 2025, and 12.65% during Q2 2025.